Two-Year safety check for Kids' bowel disease treatment
NCT ID NCT06405087
Summary
This study aims to learn about the long-term safety of vedolizumab injections in children and teenagers with ulcerative colitis or Crohn's disease. About 70 participants who responded well to the treatment in a previous study will continue receiving injections for up to 2 years, while others will be observed. Researchers will track any medical problems, hospital visits, and quality of life during this extended treatment period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Juntendo University Hospital
RECRUITINGBunkyo-ku, Tokyo, 113-8431, Japan
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.